Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 18 Aug 2025

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review

in Hematologic Malignancies

Junjun Bai
Yi Zhang
Kangqi Lv
Bei Zhang
Hongxia Wang
Zhixin Pei
Yingxin Zhao
Jingjing Gu
Huimin Wu
Qinglin Song

Frontiers in Oncology

doi 10.3389/fonc.2025.1635856

1,507 views

Original Research

Published on 13 Aug 2025

Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patients

in Hematologic Malignancies

Steven Pierre Hiltgen
Heike A. Bischoff-Ferrari
Michael Gagesch
Alexander Kaltenborn
Markus G. Manz
Max J. Rieger
Rahel Schwotzer
Sebastian M. Stolz
Thorsten Zenz
Wiebke Rösler

Frontiers in Oncology

doi 10.3389/fonc.2025.1570889

1,613 views

Case Report

Published on 13 Aug 2025

Case Report: Simnotrelvir/Ritonavir are effective in shortening the course of prolonged SARS-CoV-2 infection during anti-CD20 maintenance therapy in patients with follicular lymphoma

in Hematologic Malignancies

Jing Yang
Shengke Tu
Hui Peng
Yuanyuan Peng
Min Li
Kui Song

Frontiers in Oncology

doi 10.3389/fonc.2025.1583932

1,622 views

Original Research

Published on 13 Aug 2025

Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodology

in Hematologic Malignancies

Attilio Guarini
Valentina Bozzoli
Sabino Ciavarella
Michele Cimminiello
Francesca Donatelli
Angelo Fama
Vincenza Fernanda Fesce
Vincenzo Fraticelli
Francesco Gaudio
Giuseppina Greco

Frontiers in Oncology

doi 10.3389/fonc.2025.1627175

2,979 views

Case Report

Published on 13 Aug 2025

Novel e4a2 BCR∷ABL1 transcript with insertion of CSE1L exons 9 and 10 in a CML patient: a case report

in Hematologic Malignancies

Sara Di Giusto
Eleonora Toffoletti
Cinzia Cozzarolo
Tomas Liani
Moira Moro
Renato Fanin
Daniela Damiani
Mario Tiribelli

Frontiers in Oncology

doi 10.3389/fonc.2025.1596256

1,432 views

Original Research

Published on 12 Aug 2025

Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study

in Hematologic Malignancies

Tingting Jiang
Zailin Yang
Xinyi Tang
Na Fan
Zuhai Hu
Jieping Li
Tingting Liu
Yu Peng
Shuang Chen
Bingling Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1566905

2,170 views
1 citation

Case Report

Published on 08 Aug 2025

Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review

in Hematologic Malignancies

Xiaohong Liu
Xiujuan Zhang
Hongxia Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1644661

2,317 views
1 citation

Case Report

Published on 06 Aug 2025

Cholestatic liver injury due to leukemic infiltration in HOX11-positive acute monocytic leukemia: a case report

in Hematologic Malignancies

Huiping Xu
Qunqing She
Linjun Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1620271

1,544 views

Case Report

Published on 06 Aug 2025

Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab

in Hematologic Malignancies

Erin A. Dean
Li-Jun Yang
Robert P. Seifert
John R. Wingard

Frontiers in Oncology

doi 10.3389/fonc.2025.1630929

2,433 views

Original Research

Published on 30 Jul 2025

Identification and visualization of fusion gene subtypes in APL using spatial attention mechanisms in vision models

in Hematologic Malignancies

Peirou Yan
Guo Pu
Ping Wu
Lijun Wen
Suning Chen
Song Xue

Frontiers in Oncology

doi 10.3389/fonc.2025.1619296

1,858 views

Perspective

Published on 30 Jul 2025

A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma

in Hematologic Malignancies

Alfred L. Garfall
Rahul Banerjee
Laurent Frenzel
Cyrus Khandanpour
Yi Lin
Erica Ottoni
Robert Rifkin
Sarah Rockwell
Cesar Rodriguez
Humberto Villefort

Frontiers in Oncology

doi 10.3389/fonc.2025.1630146

7,844 views

Review

Published on 29 Jul 2025

Nestin in multiple myeloma: emerging insights into a potential therapeutic target

in Hematologic Malignancies

Yingmiao Wu
Ji Luo
Yue Zhou
Jiaoya Lin
Yajie Wu
Shuai Zheng
Jiao Chen
Feifei Che
Qiang Wang
Ling Zhong

Frontiers in Oncology

doi 10.3389/fonc.2025.1596928

1,937 views

Case Report

Published on 29 Jul 2025

Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity

in Hematologic Malignancies

HuiLing Chen
Wanli Hu
Chengcheng Ma
Miaomiao Zhang
Fuhua Yang
Pengyun Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1630715

1,603 views

Original Research

Published on 28 Jul 2025

Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database

in Hematologic Malignancies

Huiling Zhang
Yaping Huang
Chengjie Ke
Maohua Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1618267

2,539 views

Original Research

Published on 25 Jul 2025

NAP1L5 in acute myeloid leukemia: a prognostic biomarker and potential therapeutic target

in Hematologic Malignancies

Meng Wang
Zhibin Xie
Yuanyuan Tan
Yan Zhou
Tingting Zhang
Yuqing Du
Huan Wu
Lili Zhou
Jian Ge

Frontiers in Oncology

doi 10.3389/fonc.2025.1617564

1,956 views

Mini Review

Published on 25 Jul 2025

Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review

in Hematologic Malignancies

Liqing Yang
Meijuan Huang
Yuanzhong Chen
Yong Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1623528

2,812 views
1 citation

Case Report

Published on 23 Jul 2025

Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts

in Hematologic Malignancies

Yifan Wang
Shengyu Jin

Frontiers in Oncology

doi 10.3389/fonc.2025.1622820

2,090 views

Case Report

Published on 21 Jul 2025

Case Report: A novel t(15;17)(q24;q11.2) translocation involving NF1::SCAMP5 fusion in a patient with myeloproliferative neoplasms

in Hematologic Malignancies

Yuying Chang
Yakun Chen
Weiwei Zhao
Guomin Shen
Sujuan Guo
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1600963

1,945 views

Original Research

Published on 21 Jul 2025

Frontline brentuximab vedotin-based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials

in Hematologic Malignancies

Yue Yang
Shu-rong Liu
Li Wang
Rui Zhang
Jing Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1636923

2,774 views
1 citation

Original Research

Published on 10 Jul 2025

Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan

in Hematologic Malignancies

John G. Gribben
Emmanuel Bachy
Markqayne Ray
Kathryn Krupsky
Kathleen Beusterien
Lewis Kopenhafer
Sara Beygi
Timothy Best
Graeme Ball
Oliver Will

Frontiers in Oncology

doi 10.3389/fonc.2025.1589722

3,017 views

Original Research

Published on 09 Jul 2025

Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea

in Hematologic Malignancies

Gi-June Min
Ka Young Kim
Tong Yoon Kim
Young-Woo Jeon
Byung-Su Kim
Seung-Ah Yahng
Ki-Seong Eom
Seok-Goo Cho

Frontiers in Oncology

doi 10.3389/fonc.2025.1614506

2,114 views

Case Report

Published on 09 Jul 2025

Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review

in Hematologic Malignancies

Hongjuan Dong
Rui Wang
Lu Cheng
Shirong Ma
Li Zhu
Jing Zhao
Guangxun Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1632039

2,619 views
1 citation

Original Research

Published on 08 Jul 2025

ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming

in Hematologic Malignancies

Lan Yang
Yanqiu Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1603060

1,808 views

Original Research

Published on 08 Jul 2025

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India

in Hematologic Malignancies

Rajiv Mohan
Chitrakshi Nagpal
Swasthik Upadhya
Akash Kumar
Rajesh Khadgawat
Sameer Bakhshi
Deepam Pushpam

Frontiers in Oncology

doi 10.3389/fonc.2025.1598104

1,941 views

1,998 articles

articles

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review

Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patients

Case Report: Simnotrelvir/Ritonavir are effective in shortening the course of prolonged SARS-CoV-2 infection during anti-CD20 maintenance therapy in patients with follicular lymphoma

Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodology

Novel e4a2 BCR∷ABL1 transcript with insertion of CSE1L exons 9 and 10 in a CML patient: a case report

Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study

Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review

Cholestatic liver injury due to leukemic infiltration in HOX11-positive acute monocytic leukemia: a case report

Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab

Identification and visualization of fusion gene subtypes in APL using spatial attention mechanisms in vision models

A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma

Nestin in multiple myeloma: emerging insights into a potential therapeutic target

Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity

Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database

NAP1L5 in acute myeloid leukemia: a prognostic biomarker and potential therapeutic target

Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review

Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts

Case Report: A novel t(15;17)(q24;q11.2) translocation involving NF1::SCAMP5 fusion in a patient with myeloproliferative neoplasms

Frontline brentuximab vedotin-based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials

Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan

Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea

Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review

ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India